Evaluation of N-(phenylmethyl)-4-[5-(phenylmethyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-4-yl]benzamide inhibitors of Mycobacterium tuberculosis growth

被引：22
|
作者：
Wall, Michael D.
Oshin, Michael
Chung, Gavin A. C.
Parkhouse, Tony
Gore, Andrea
Herreros, Esperanza
Cox, Brian
Duncan, Ken
Evans, Brian
Everett, Martin
Mendoza, Alfonso
机构：
[1] GlaxoSmithKline, Med Res Ctr, Stevenage SG1 2NY, Herts, England
[2] GlaxoSmithKline, Harlow CM19 5AW, Essex, England
[3] GlaxoSmithKline, E-28760 Madrid, Spain
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 10期
关键词：
Mycobacterium tuberculosis; imidazopiperidines; InhA;
D O I：
10.1016/j.bmcl.2007.02.078
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The biological evaluation of imidazopiperidines as FAS II inhibitors of Mycobacterium tuberculosis growth has been carried out with a view to assessment of potential as lead compounds for the development of a new TB drug. A summary of the hit evaluation and current challenges is described herein. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码：2740 / 2744
页数：5
相关论文
共 50 条
  • [31] Synthesis and reaction of 5,6,7,8-tetrahydro-4H-oxazolo[4,5-c]azepin-4-ones
    Koh, YK
    Bang, KH
    Kim, HS
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2001, 38 (01) : 89 - 92
  • [32] 4-{(4-Chlorophenyl)[4-(4-methylphenyl)-1,2,3-selenadiazol-5-yl]methyl}-4,5,6,7-tetrahydro-1,2,3-benzoselenadiazole
    Muthukumaran, J.
    Nishandhini, M.
    Chitra, S.
    Muthusubramanian, S.
    Manisankar, P.
    Bhattacharya, Suman
    Krishna, R.
    Jeyakanthan, J.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O1421 - U763
  • [33] N-(4-Chlorophenyl)-5-(4,5-dihydro-1H-imidazol-2-yl)thieno[2,3-b]pyridin-4-amine
    Bernardino, Alice M. R.
    Pinheiro, Luiz C. S.
    Tiekink, Edward R. T.
    Wardell, James L.
    Wardell, Solange M. S. V.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2135 - +
  • [34] 1-[4-(4-Nitrophenyl)piperazin-1-yl]-2-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)ethanone
    Mu, Shuai
    Yang, Miao
    Liu, Deng-Ke
    Liu, Chang-Xiao
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2010, 66 : O2762 - U2103
  • [35] 2-[4-(4-Methylphenylsulfonyl)piperazin-1-yl]-1-(4,5,6,7-tetrahydrothieno[3,2-c]-pyridin-5-yl)ethanone
    Niu, Duan
    Huang, Shu-Yun
    Wang, Ping-Bao
    Liu, Deng-Ke
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O2134 - U1401
  • [36] SYNTHESIS AND IN-VITRO CYTOSTATIC ACTIVITY OF 4-(BENZYLIDENEAMINO)-5-(PYRIDIN-4-YL)-4H-1,2,4-TRIAZOLE-3-THIOLS
    Ramjith, U. S.
    Shakkeel, K. V. Muhammed
    Nabeel, C. K.
    INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY, 2013, 23 (02) : 155 - 158
  • [37] 4-[5-(4-Fluorophenyl)-3-isopropylisoxazol-4-yl]pyridin-2(1H)-one
    Abadleh, Mohammed
    Peifer, Christian
    Kinkel, Katrin
    Schollmeyer, Dieter
    Laufer, Stefan
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : o1423 - o1425
  • [38] 4-(4-Fluorophenyl)-3-(pyridin-4-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazol-5-amine
    Abu Thaher, Bassam
    Koch, Pierre
    Schollmeyer, Dieter
    Laufer, Stefan
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2603 - +
  • [39] Synthesis and pharmacological evaluation of 5-[2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine derivatives as platelet aggregation inhibitors
    Challa, Nageswar Rao
    Mamidisetty, Balaji
    Ghanta, Mahesh Reddy
    Padi, Pratap Reddy
    JOURNAL OF SAUDI CHEMICAL SOCIETY, 2014, 18 (05) : 513 - 519
  • [40] Asymmetric synthesis of (-)-(4R, 5R)-4-[5-(benzo[1, 3]dioxo1-5-y1)-4-hydroxyl-1-(pyridin-2-yl)-4, 5-dihydro-1H-pyrazol-3-yl]benzamide
    Li, XZ
    Dai, MP
    Xiao, JH
    Li, S
    CHINESE CHEMICAL LETTERS, 2005, 16 (09) : 1137 - 1139
12345